文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

ARC模型的开发与验证:预测新型冠状病毒肺炎患者急性呼吸衰竭

Development and Validation of ARC, a Model for Anticipating Acute Respiratory Failure in Coronavirus Disease 2019 Patients.
PubMed 文献 · Crit Care Explor · 2021-06-04
一句话结论ARC模型可持续监测并预测COVID-19住院患者急性呼吸衰竭,中位提前32小时预警,敏感度77%、特异度75%。

本研究为回顾性队列研究,纳入8家医院共2015例COVID-19住院患者,开发并验证了可临床解释、持续监测的急性呼吸衰竭预测模型ARC。模型随电子健康记录中新记录的体征和实验室检查结果持续更新。验证显示ARC预测急性呼吸衰竭的敏感度77%、特异度75%,中位提前32小时预警,超过80%的真阳性警报发生在非ICU环境。结论提示持续监测预后模型可能有助于从被动应对转向主动升级治疗。

要点

  • ARC模型在8家医院2015例COVID-19住院患者中开发并验证,持续监测并预测急性呼吸衰竭。
  • 验证中ARC达到敏感度77%、特异度75%,中位提前32小时预测急性呼吸衰竭。
  • 超过80%的真阳性警报发生在非ICU环境,提示非ICU住院COVID-19患者存在持续进展风险。
  • ARC随电子健康记录中新记录的体征和实验室结果持续更新,区别于既往模型。
  • 模型分析的重要预测因素与既往研究一致,并区分COVID-19与其他感染所致肺炎的预测特征。

适用人群与场景

  • 住院的COVID-19阳性患者共2015例,来自8家医院、两个地理区域。
  • 超过80%的真阳性警报发生在非ICU环境,提示非ICU住院COVID-19患者为持续监测重点人群。

研究设计与关键结果

  • 研究类型为回顾性队列,用于算法训练、测试和验证,纳入8家医院共2015例住院COVID-19阳性患者,无干预。
  • 开发并验证了ARC模型,即可临床解释、持续监测的住院COVID-19患者急性呼吸衰竭预后模型,随电子健康记录中新记录的体征和实验室结果持续更新。
  • 验证显示ARC敏感度77%、特异度75%,中位在急性呼吸衰竭发生前32小时预测。
  • 超过80%的真阳性警报发生在非ICU环境。
  • 模型分析的最重要临床预测因素与其他研究者识别的关键危险因素一致,并提供了关键因素首次出现异常的时间以及区分COVID-19与其他感染所致肺炎的预测特征的新见解。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(算法训练、测试和验证)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,持续监测预后模型有潜力促进对治疗升级采取 anticipatory( anticipatory而非被动应对)的方法,例如更早启动重症治疗或对高风险患者进行结构化监测和治疗干预。
  • 对非ICU住院的COVID-19患者,ARC模型可能有助于识别急性呼吸衰竭高风险者,中位提前32小时预警。
  • 模型随电子健康记录中新记录的体征和实验室结果持续更新,可能适用于需要动态风险评估的住院场景。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate factors predictive of clinical progression among coronavirus disease 2019 patients following admission, and whether continuous, automated assessments of patient status may contribute to optimal monitoring and management.

DESIGN: Retrospective cohort for algorithm training, testing, and validation.

SETTING: Eight hospitals across two geographically distinct regions.

PATIENTS: Two-thousand fifteen hospitalized coronavirus disease 2019-positive patients.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Anticipating Respiratory failure in Coronavirus disease (ARC), a clinically interpretable, continuously monitoring prognostic model of acute respiratory failure in hospitalized coronavirus disease 2019 patients, was developed and validated. An analysis of the most important clinical predictors aligns with key risk factors identified by other investigators but contributes new insights regarding the time at which key factors first begin to exhibit aberrency and distinguishes features predictive of acute respiratory failure in coronavirus disease 2019 versus pneumonia caused by other types of infection. Departing from prior work, ARC was designed to update continuously over time as new observations (vitals and laboratory test results) are recorded in the electronic health record. Validation against data from two geographically distinct health systems showed that the proposed model achieved 75% specificity and 77% sensitivity and predicted acute respiratory failure at a median time of 32 hours prior to onset. Over 80% of true-positive alerts occurred in non-ICU settings.

CONCLUSIONS: Patients admitted to non-ICU environments with coronavirus disease 2019 are at ongoing risk of clinical progression to severe disease, yet it is challenging to anticipate which patients will develop acute respiratory failure. A continuously monitoring prognostic model has potential to facilitate anticipatory rather than reactive approaches to escalation of care (e.g., earlier initiation of treatments for severe disease or structured monitoring and therapeutic interventions for high-risk patients).

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Saria S, Schulam P, Yeh BJ, et al. Development and Validation of ARC, a Model for Anticipating Acute Respiratory Failure in Coronavirus Disease 2019 Patients. Crit Care Explor. 2021. PMID: 34104894. doi:10.1097/CCE.0000000000000441

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。